News and Community

Inbrija, Jiangxi Kvvit Pharmaceutical, Levodopa Inhalation Powder, Merz Therapeutics, Neurological Disease, Parkinson's Disease

May 26, 2026

Merz Therapeutics and Kvvit Sign Exclusive Agreement for INBRIJA (levodopa inhalation powder) in Mainland China, Hong Kong, and Macao